HUMA vs ABOS
Comparison between Humacyte Inc (HUMA, Company) and Acumen Pharmaceuticals Inc (ABOS, Company).
Both HUMA and ABOS are from the Healthcare sector.
5-Year PerformanceABOS has outperformed HUMA, delivering a return of -31.6% compared to -42.2%
HUMA vs ABOS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
HUMA vs ABOS - Historical Returns
Returns include dividend reinvestment.
HUMA vs ABOS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | HUMA | ABOS |
|---|---|---|
| 2026 | -25.25% | +10.89% |
| 2025 | -81.46% | +14.05% |
| 2024 | +74.74% | -59.34% |
| 2023 | +34.60% | -27.00% |
| 2022 | -71.49% | -19.76% |
| 2021 | -33.85% | -66.37% |
HUMA vs ABOS Drawdown Comparison
The maximum drawdown for HUMA was -96.62%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The current HUMA drawdown is -95.71%. The current ABOS drawdown is -88.95%.
| Rank | HUMA | ABOS |
|---|---|---|
| #1 | -96.62% Sep 1, 2021 - Mar 30, 2026 | -95.56% Jul 2, 2021 - Apr 17, 2025 |
Correlation
Correlation between HUMA and ABOS is 0.69 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks